FDA Inspection 1191700 — MedisourceRx
The FDA completed an inspection of MedisourceRx on November 4, 2022 in Los Alamitos, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Los Alamitos, CA (United States)